PH4 Syrup 170 ml

Babies: Not applicable. Lactating mothers: It is safe to use this medicine during breastfeeding.
Human studies suggest that the drug does not cause significant risk to the baby. Pregnancy: Please consult your doctor before using this medicine.
Information regarding the use of this medicine during pregnancy is not available. Alcohol: It is unsafe to consume alcohol while using this medicine.
Driving: This medicine does not affect your ability to drive. It is safe to go while using this medicine.
Kidney: Please consult your doctor before using this medicine. There is limited information available on the use of this medicine in patients with kidney disease.
Liver: Please consult your doctor before using this medicine. There is limited information available on the use of this medicine in patients with liver disease..

Diarrhea Constipation Chalky taste.

It is a combination medicine used to treat acidity, bloating, indigestion, and stomach ulcers. Magaldrate is an inorganic salt that neutralizes excess acid in the stomach.
Simethicone is an antifoaming agent that disintegrates gas bubbles and allows easy passage of gas..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as long as prescribed by your doctor • Check the label for directions before using this medicine • If you experience abdominal pain, nausea, diarrhoea, and constipation while taking this medicine, inform your doctor • Avoid consumption of alcohol while taking this medicine • Take this medicine with food to get better results as prescribed by your doctor.

• Magaldrate + Simethicone + Glimepiride: Concurrent use of this medicine alters the blood glucose levels • Magaldrate + Simethicone + Raltegravir: Concurrent use leads to a decrease in the therapeutic effect of raltegravir • Magaldrate + Simethicone + Enalapril: Concurrent use leads to an increase in the risk of potassium levels • Magaldrate + Simethicone + Chloroquine: Concurrent use leads to an increase in the risk of irregular heart rate • Magaldrate + Simethicone + Aspirin: Concurrent use leads to a decrease in the therapeutic effect of aspirin.